Farnesylation amino acid targeted editing

Farnesylation amino acid targeted editing has been studied in 2 papers since 2026: none in people yet, 2 in cells; 2 in the past year. No study of it in people or animals has been published yet. The newest story, Oct 2, 2026: “Base editing of the lamin farnesylation motif rescues progeria phenotypes in organoids”.

InterventionPreclinical

2 papers study it5 findingsUpdated

See all 2 papers on farnesylation amino acid targeted editing

At a glance

The findings reach cells, none yet in people. 1 lab in 1 country.

None of its findings points the other way.

Cells: a single group. Worms or flies, mice and humans: nothing yet.
  • 1 lab in 1 country
  • Funders: Ministry of Science and ICT, South Korea and 2 more
  • Cells2

What did studies of farnesylation amino acid targeted editing find?

3

Studies of farnesylation amino acid targeted editing measured 3 outcomes: progeria, DNA repair and progerin.

Progeria

downin human cells1

1 study
  1. Farnesylation amino acid targeted editing decreases progeria in HGPS neuromuscular organoids.

    “transient delivery of FATE mRNA conjugated with lipid nanoparticles to HGPS NMOs achieves efficient base editing and phenotypic rescue.”

    Cellsin HGPS neuromuscular organoids

    Base editing of the lamin farnesylation motif rescues progeria phenotypes in organoids

    Nature communications

More on Progeria

DNA repair

upin human cells1

1 study
  1. Farnesylation amino acid targeted editing improves DNA repair in HGPS neuromuscular organoids.

    “restores 53BP1 mobility, reconstitutes DNA repair foci, and normalizes heterochromatin architecture.”

    Cellsin HGPS neuromuscular organoids

    Base editing of the lamin farnesylation motif rescues progeria phenotypes in organoids

    Nature communications

More on DNA repair

Progerin

downin human cells1

1 study
  1. Farnesylation amino acid targeted editing decreases progerin in HGPS neuromuscular organoids.

    “FATE eliminates perinuclear progerin, restores 53BP1 mobility, reconstitutes DNA repair foci, and normalizes heterochromatin architecture.”

    Cellsin HGPS neuromuscular organoids

    Base editing of the lamin farnesylation motif rescues progeria phenotypes in organoids

    Nature communications

More on Progerin

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 1Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 0Oct 2026: 0Nov 2026: 02 papers in 12 months